Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,282 INR | -1.31% | -4.87% | -5.71% |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Mar. 28 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.71% | 1.18B | |
+21.12% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.19% | 13.79B | |
+45.37% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, H1 2024 Earnings Call, Nov 09, 2023